{
    "clinical_study": {
        "@rank": "161471", 
        "arm_group": [
            {
                "arm_group_label": "Sleep Education", 
                "arm_group_type": "Active Comparator", 
                "description": "Weekly educational emails sent to participants with information about sleep science and tips for better sleep."
            }, 
            {
                "arm_group_label": "Cognitive Behavioral Therapy for Insomnia", 
                "arm_group_type": "Experimental", 
                "description": "Behavioral treatment (5 component)"
            }, 
            {
                "arm_group_label": "Sleep Restriction Therapy", 
                "arm_group_type": "Experimental", 
                "description": "Brief sleep restriction therapy."
            }
        ], 
        "brief_summary": {
            "textblock": "Insomnia is recognized as the most prevalent and \"costly\" sleep disorders and is associated\n      with considerable morbidity including significantly reduced quality of life, impaired work\n      performance, and increased risk for major depressive disorder.1-4  Insomnia is a key symptom\n      of the menopausal transition. Cognitive-behavioral therapy for insomnia (CBT-I) yields\n      equivalent short-term efficacy and superior long-term durability to pharmacological\n      treatment of insomnia.  The efficacy of cognitive behavioral therapy for insomnia comorbid\n      with menopause will be tested."
        }, 
        "brief_title": "Behavioral Treatment of Menopausal Insomnia; Sleep and Daytime Outcomes", 
        "completion_date": {
            "#text": "January 2018", 
            "@type": "Anticipated"
        }, 
        "condition": "Menopause", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  post-menopausal insomnia\n\n        Exclusion Criteria:\n\n          -  unstable medical conditions"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "45 Years"
        }, 
        "enrollment": {
            "#text": "150", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 6, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01933295", 
            "org_study_id": "NR013959", 
            "secondary_id": "R01NR013959-01"
        }, 
        "intervention": [
            {
                "arm_group_label": "Cognitive Behavioral Therapy for Insomnia", 
                "intervention_name": "Cognitive Behavioral Therapy for Insomnia", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": "Sleep Education", 
                "intervention_name": "Sleep Education", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": "Sleep Restriction Therapy", 
                "intervention_name": "Sleep Restriction Therapy", 
                "intervention_type": "Behavioral"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": "treatment", 
        "lastchanged_date": "March 19, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Detroit", 
                    "country": "United States", 
                    "state": "Michigan", 
                    "zip": "48202"
                }, 
                "name": "Henry Ford Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "3", 
        "official_title": "Behavioral Treatment of Menopausal Insomnia; Sleep and Daytime Outcomes", 
        "other_outcome": {
            "description": "Subjects will be evaluated at pre treatment, post treatment and at approximately 6 months follow up. For each participant, self report sleep diaries will be measured in the home nightly throughout the 2-week baseline, treatment protocols, during the 2 weeks immediately post-treatment and for 2 weeks during follow up assessment at 6 months post treatment.\nHome based measures (Diary): Wake after sleep onset; sleep efficiency; total sleep time; sleep latency; number of awakenings", 
            "measure": "Self-Reported Sleep (Diary)", 
            "safety_issue": "No", 
            "time_frame": "8 months"
        }, 
        "overall_contact": {
            "email": "cfellma1@hfhs.org", 
            "last_name": "Cynthia Fellman-Couture, RN", 
            "phone": "313-916-4150"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Henry Ford Hospital Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Subjects will be evaluated at pre treatment, post treatment and at approximately 6 months follow up. A total of 4 standarized nocturnal PSGs will be performed for each participant (screening night, baseline assessment, and post-treatment night 1 and post treatment night 2. For each participant, self report sleep diaries will be measured in the home nightly throughout the 2-week baseline, treatment protocols, during the 2 weeks immediately post-treatment and for 2 weeks during follow up assessment at 6 months post treatment.", 
            "measure": "Sleep", 
            "safety_issue": "No", 
            "time_frame": "8 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01933295"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Henry Ford Health System", 
            "investigator_full_name": "Christopher Drake", 
            "investigator_title": "Bioscientific Staff", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Subjects will be evaluated at pre treatment, post treatment and at approximately 6 months follow up. Depression will be measured by the administration of the Beck Depression Inventory questionnaire(BDI-II).", 
                "measure": "Depression", 
                "safety_issue": "No", 
                "time_frame": "8 months"
            }, 
            {
                "description": "Subjects will be evaluated at pre treatment, post treatment and at approximately 6 months follow up", 
                "measure": "Quality of life", 
                "safety_issue": "No", 
                "time_frame": "8 months"
            }
        ], 
        "source": "Henry Ford Health System", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "National Institute of Nursing Research (NINR)", 
                    "agency_class": "NIH"
                }, 
                {
                    "agency": "Wayne State University", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University of Michigan", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Christopher Drake", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}